Cargando…
Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition
Oral administration of tumour cells induces an immune hypo-responsiveness known as oral tolerance. We have previously shown that oral tolerance to a cancer is tumour antigen specific, non-cross-reactive and confers a tumour growth advantage. We investigated the utilisation of regulatory T cell (Treg...
Autores principales: | Whelan, Maria C., Casey, Garrett, Larkin, John O., Guinn, Barbara-ann, O'Sullivan, Gerald C., Tangney, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022586/ https://www.ncbi.nlm.nih.gov/pubmed/24832130 http://dx.doi.org/10.1371/journal.pone.0097602 |
Ejemplares similares
-
Optimised electroporation mediated DNA vaccination for treatment of prostate cancer
por: Ahmad, Sarfraz, et al.
Publicado: (2010) -
Identification of the Antigens Recognised by Colorectal Cancer Patients Using Sera from Patients Who Exhibit a Crohn’s-like Lymphoid Reaction
por: Boncheva, Viktoriya B., et al.
Publicado: (2022) -
Control and Augmentation of Long-Term Plasmid Transgene Expression In Vivo in Murine Muscle Tissue and Ex Vivo in Patient Mesenchymal
Tissue
por: Morrissey, David, et al.
Publicado: (2012) -
Role of Regulatory Cells in Oral Tolerance
por: Wawrzyniak, Marcin, et al.
Publicado: (2017) -
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance
Publicado: (1996)